NHS National Generic Pharmaceuticals Transition 2023_1

Concepts

• pharmaceutical products
• nhs national generic pharmaceuticals
• runcorn
• period of framework agreement
• nhs national generics pharmaceuticals
• nhs national generic pharmaceuticals transition
• nhs national generics pharmaceuticals transition
• 00 - transition products
• total maximum duration of the framework agreement
• offer reference number

Location

Description

Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months) CM/PHG/22/5666/01 - Orals Oral (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 months)

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 05a(iii) - Product listing and usage - Oral products#2 Document No. 05a(iii) - Product listing and usage - Oral products#2.xlsx Document No. 00 - Read Me First Document#2 Document No. 00 - Read Me First Document#2.docx Document No. 01 - Invitation to offer covering letter#2 Document No. 01 - Invitation to offer covering letter#2.docx Document No. 02 - Terms of offer#2 Document No. 02 - Terms of offer#2.doc Document No. 03 - Framework Agreement and Terms and Conditions - With Lots#2 Document No. 03 - Framework Agreement and Terms and Conditions - With Lots#2.pdf Document No. 05a(i) - Product listing and usage - Transition products#2 Document No. 05a(i) - Product listing and usage - Transition products#2.xlsx Document No. 05a(ii) - Selectt offer schedule - Transition CM_PHG22_5666_00#2 Document No. 05a(ii) - Selectt offer schedule - Transition CM_PHG22_5666_00#2.xml Document No. 05a(iv) - Selectt offer schedule - Oral Products#2 Document No. 05a(iv) - Selectt offer schedule - Oral Products#2.xml Document No. 05b - Selectt offer schedule instructions#2 Document No. 05b - Selectt offer schedule instructions#2.docx Document No. 06 - Form of offer#2 Document No. 06 - Form of offer#2.doc Document No. 08 - Confidential information schedule#2 Document No. 08 - Confidential information schedule#2.xls Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022 Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.pdf Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements copy Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements copy.pdf Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.pdf